We are live on ! Find out more
TMO icon

Thermo Fisher Scientific

2,365 hedge funds and large institutions have $173B invested in Thermo Fisher Scientific in 2023 Q3 according to their latest regulatory filings, with 141 funds opening new positions, 967 increasing their positions, 887 reducing their positions, and 135 closing their positions.

New
Increased
Maintained
Reduced
Closed

9% more repeat investments, than reductions

Existing positions increased: 967 | Existing positions reduced: 887

4% more first-time investments, than exits

New positions opened: 141 | Existing positions closed: 135

0.89% less ownership

Funds ownership: 89.44%88.54% (-0.89%)

1% less funds holding

Funds holding: 2,3882,365 (-23)

2% less call options, than puts

Call options by funds: $1.23B | Put options by funds: $1.25B

3% less capital invested

Capital invested by funds: $178B → $173B (-$4.73B)

1% less funds holding in top 10

Funds holding in top 10: 141139 (-2)

Holders
2,365
Holders Change
-23
Holders Change %
-0.96%
% of All Funds
37.53%
Holding in Top 10
139
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-1.42%
% of All Funds
2.21%
New
141
Increased
967
Reduced
887
Closed
135
Calls
$1.23B
Puts
$1.25B
Net Calls
-$26.6M
Net Calls Change
+$128M
Name Holding Trade Value Shares
Change
Change in
Stake
EGM
601
Engineers Gate Manager
New York
$10.2M -$165K -309 -2%
CM
602
Churchill Management
California
$10.2M +$6.93K +13 +0.1%
HVIA
603
Hudson Valley Investment Advisors
New York
$10.2M -$726K -1,362 -6%
AAS
604
Avantax Advisory Services
Texas
$10.2M +$125K +234 +1%
NMERB
605
New Mexico Educational Retirement Board
New Mexico
$10.2M +$533K +1,000 +5%
NO
606
Ninety One
South Africa
$10.1M +$3.86M +7,245 +57%
Capstone Investment Advisors
607
Capstone Investment Advisors
New York
$10.1M +$1.83M +3,429 +21%
HP
608
Hound Partners
New York
$10M -$126K -237 -1%
BFM
609
Boston Financial Management
Massachusetts
$9.94M -$298K -560 -3%
RHDIC
610
R.H. Dinel Investment Counsel
California
$9.94M
FPFS
611
First Personal Financial Services
North Carolina
$9.93M +$191K +359 +2%
M
612
MOTCO
Texas
$9.9M +$51.7K +97 +0.5%
PAIM
613
Punch & Associates Investment Management
Minnesota
$9.84M +$29.8K +56 +0.3%
RJT
614
Raymond James Trust
Florida
$9.78M +$1.76M +3,295 +21%
AT
615
AMF Tjänstepension
Sweden
$9.77M -$17.3M -32,451 -63%
Verition Fund Management
616
Verition Fund Management
Connecticut
$9.75M +$6.48M +12,161 +171%
MIM
617
Martin Investment Management
Florida
$9.73M -$457K -857 -4%
MYAM
618
Meiji Yasuda Asset Management
Japan
$9.64M +$893K +1,675 +10%
TC
619
Telemus Capital
Michigan
$9.61M +$84.2K +158 +0.8%
GHA
620
GW Henssler & Associates
Georgia
$9.55M -$257K -482 -2%
AHB
621
Abner Herrman & Brock
New Jersey
$9.49M +$84.7K +159 +0.9%
WBC
622
Westpac Banking Corp
Australia
$9.42M -$2.32M -4,349 -19%
ZCM
623
Ziegler Capital Management
Illinois
$9.42M -$122K -229 -1%
PCOC
624
Power Corp of Canada
Canada
$9.4M -$378K -709 -4%
NWM
625
Nicola Wealth Management
British Columbia, Canada
$9.36M

TMO Hedge Fund Activity: Q3 2023 in Review

2,365 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q3 2023, worth a combined $173B — down 2.7% from $178B a quarter earlier.

Buyers outnumbered sellers: 141 funds opened new TMO positions and 135 closed out — a net gain of 6 holders — while 967 added to existing stakes and 887 trimmed.

The largest buyer was DZ Bank, adding an estimated $755M. The largest seller was Arthur M. Cohen & Associates, cutting an estimated $1.66B.

  • 2,365 institutional investors held Thermo Fisher Scientific (TMO) as of Q3 2023, down from 2,388 in Q2 2023.
  • Funds reported $173B of Thermo Fisher Scientific stock for Q3 2023, down 2.7% quarter-over-quarter.
  • 141 funds opened new Thermo Fisher Scientific positions in Q3 2023 and 135 closed out, a net change of +6 holders.
  • The largest Thermo Fisher Scientific buyer in Q3 2023 was DZ Bank, an estimated $755M added.
  • The largest Thermo Fisher Scientific seller in Q3 2023 was Arthur M. Cohen & Associates, an estimated $1.66B sold.

Based on aggregated 13F filings for Q3 2023.